Recombinant Human VC Protein，His

The research on VC (Vitamin C) recombinant proteins stems from the increasing interest in the therapeutic potential of vitamin C, particularly in oncology and immunology. Vitamin C, or ascorbic acid, is known for its essential role in various biological functions, including antioxidant activity and collagen synthesis. However, its application in clinical settings has been limited by challenges related to stability, bioavailability, and effective delivery systems. The advent of recombinant DNA technology has opened new avenues for producing VC in more stable and bioactive forms. Researchers aim to express VC as a recombinant protein using various host organisms, enabling better production scalability and enhanced biological activity. This approach not only facilitates the study of vitamin C's mechanisms but also aims to overcome the limitations of traditional supplementation methods. Additionally, the exploration of VC recombinant proteins is timely, as there is a growing body of evidence suggesting that vitamin C can enhance the efficacy of certain cancer therapies and bolster immune responses. Thus, the focus on VC recombinant protein research is driven by its potential to offer new therapeutic strategies in modern medicine, aimed at improving patient outcomes and exploring vitamin C's multifaceted roles in health and disease.